Financhill
Buy
67

CPRX Quote, Financials, Valuation and Earnings

Last price:
$23.65
Seasonality move :
15.63%
Day range:
$23.31 - $24.07
52-week range:
$14.75 - $26.16
Dividend yield:
0%
P/E ratio:
15.06x
P/S ratio:
5.57x
P/B ratio:
3.63x
Volume:
1.1M
Avg. volume:
1.2M
1-year change:
45.81%
Market cap:
$2.9B
Revenue:
$491.7M
EPS (TTM):
$1.57

CPRX Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Catalyst Pharmaceuticals shares anticipate an average target of $34.00, ranging from a low estimate of $31.00 to a high estimate of $40.00. This average target implies a growth of 43.76% compared to the current stock price of $23.65.

Consensus Price Target

$34.00

Highest Price Target

$40.00

Lowest Price Target

$31.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 5 7 7

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

CPRX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 42x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is down 31.81% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 24.57% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 24.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock